{"id":205120,"name":"SOLVD HEALTH","slug":"solvd-health","state":"PA","country":"United States of America","description":"Health Intelligence Company.","totalSpending":450000,"filings":7,"yearlySpending":[{"year":2020,"income":250000},{"year":2021,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["PENN AVENUE PARTNERS"],"lobbyists":["DANIELLA LANDAU","TIMOTHY HANNEGAN","JERR ROSENBAUM","JAY SULZMANN"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office","Food & Drug Administration (FDA)","Centers For Disease Control & Prevention (CDC)","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["To promote awareness among policy makers of Prescient Medicines novel genetic testing technology designed to objectively assess an individuals risk of opioid addiction prior to opioid exposure.","To promote awareness among policy makers of Prescient Medicines novel genetic testing technology designed to objectively assess an individuals risk of opioid addiction prior to opioid exposure.","To promote awareness among policy makers of Prescient Medicines novel genetic testing technology designed to objectively assess an individuals risk of opioid addiction prior to opioid exposure.","To promote awareness among policy makers of Prescient Medicines novel genetic testing technology designed to objectively assess an individuals risk of opioid addiction prior to opioid exposure.","To promote awareness among policy makers of SOLVD Health novel genetic testing technology designed to objectively assess an individuals risk of opioid addiction prior to opioid exposure."]}